BetterLife To Present BETR-001 Preclinical Data at the 61ST Annual Meeting of the American College of Neuropsychopharmacology in Phoenix, Arizona Pharmaceutical Investing
Lobe Sciences Provides an Update to Clinical Development Plans for Its Proprietary Psilocin Product, L-130 Pharmaceutical Investing
COMPASS Pathways to participate in upcoming Evercore ISI HealthCONx Conference Psychedelics Investing
Seelos Therapeutics to Hold a Research and Development Update Conference Call and Webcast on December 15, 2022 Psychedelics Investing
Goodness Growth Holdings Announces Voting Results of Annual and General Meeting of Shareholders Psychedelics Investing
Nirvana Life Sciences Inc. announces agreement to acquire the licensed distributor of a Patented, WHO approved, herbal treatment for opiate addiction Company News
Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
